P/E at 59.8 vs Industry's 66.8: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount to Industry P/E

The current P/E of 59.8 for Apollo Hospitals Enterprise Ltd. stands below the hospital sector’s average of 66.8, suggesting the stock is trading at a roughly 10.5% discount relative to its peers. This valuation gap may reflect market caution despite the company’s large-cap status and robust fundamentals. The sector’s elevated P/E is often justified by growth expectations and defensive qualities inherent in healthcare services, yet Apollo Hospitals appears to be priced more conservatively. This divergence invites the question previously rated Strong Buy, what is Apollo Hospitals’ current rating? The valuation discount could be signalling a cautious stance on near-term earnings growth or competitive pressures within the hospital industry.

Performance Across Timeframes: A Mixed Momentum Story

Examining returns over multiple periods highlights a compelling performance divergence. Over the past year, Apollo Hospitals has delivered a 12.6% gain, significantly outperforming the Sensex’s 10.3% decline. This outperformance extends over longer horizons, with three-year and five-year returns of 74.2% and 80.2% respectively, dwarfing the Sensex’s 10.2% and 26.2% gains. Even the ten-year return of 576.8% versus the Sensex’s 160.4% underscores the company’s sustained growth trajectory.

However, the short-term momentum is more subdued. The stock’s one-month return is a marginal 0.2%, and the one-week performance shows a slight decline of 0.1%, though still outperforming the Sensex’s sharper losses in these periods. The three-month return of 5.1% is positive but modest, especially when contrasted with the Sensex’s 3.8% fall. This suggests a recent slowdown in momentum despite the longer-term strength — is this a temporary pause or a sign of shifting fundamentals?

Moving Average Configuration: Technical Signals

The technical setup of Apollo Hospitals reveals a nuanced picture. The stock is trading above its 20-day, 100-day, and 200-day moving averages, indicating underlying medium to long-term strength. However, it remains below the 5-day and 50-day moving averages, signalling some short-term resistance and potential consolidation. This configuration often points to a recent pullback or a pause within a broader uptrend. The stock has also recorded three consecutive days of gains, rising 1.04% in that span, which may hint at a nascent recovery phase — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Performance Context

The hospital sector has experienced mixed results recently, with some companies posting gains while others face headwinds from regulatory changes and cost pressures. Within this environment, Apollo Hospitals stands out for its relative resilience and consistent outperformance over multiple timeframes. The sector’s average P/E of 66.8 reflects investor willingness to pay a premium for healthcare stability, yet the sector’s recent volatility has tempered enthusiasm. Against this backdrop, Apollo Hospitals’ valuation discount and technical signals may be interpreted as a cautious but steady stance within a challenging sector landscape.

Rating Reassessment and Historical Context

Previously rated Strong Buy by MarketsMOJO, Apollo Hospitals had its rating updated on 15 Sep 2026. The current Mojo Score stands at 77.0, reflecting a solid but more measured outlook compared to the prior assessment. This recalibration aligns with the stock’s valuation discount and the recent technical consolidation. The rating update invites investors to consider should investors in Apollo Hospitals hold, buy more, or reconsider? The data-driven approach underscores the importance of balancing valuation, performance, and technical factors in the current market environment.

Market Capitalisation and Sector Positioning

With a market capitalisation of approximately ₹1,27,092 crores, Apollo Hospitals is a dominant large-cap player within the hospital sector. Its scale and brand recognition provide competitive advantages, yet the valuation discount relative to peers suggests the market is pricing in some near-term uncertainties. The stock’s outperformance over the last decade, with a 10-year return of 576.8%, highlights its long-term growth credentials, but the recent technical and rating adjustments reflect a more cautious stance.

Conclusion: What the Data Collectively Shows

The data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a modest valuation discount to its sector, with strong long-term performance but recent technical consolidation. The stock’s P/E ratio of 59.8 versus the industry’s 66.8 suggests a cautious market stance despite robust fundamentals. Performance across timeframes reveals sustained outperformance over years, yet the short-term momentum is less decisive, reflected in the moving average configuration and recent rating reassessment. The sector’s mixed results and regulatory environment add further complexity to the valuation and technical signals. Collectively, these factors invite investors to carefully weigh the balance between valuation, momentum, and sector dynamics — what is the current rating for Apollo Hospitals, and how should investors position themselves?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →